Continuous release of endostatin from microencapsulated engineered cells for tumor therapy

Nature Biotechnology

Volumn 19, Issue 1, 2001, Pages 35-39

  Joki, Tatsuhiro ^a,b,c   Machluf, Marcelle ^b   Atala, Anthony ^b   Zhu, Jianhong ^a,b   Seyfried, Nicholas T ^a,b   Dunn, Ian F ^a,b   Abe, Toshiaki ^c   Carroll, Rona S ^a,b   Black, Peter McL ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Angiogenesis; Encapsulation; Endostatin; Glioma

Indexed keywords

ALGINIC ACID; ANGIOGENESIS INHIBITOR; ENDOSTATIN; POLYLYSINE; PROTEIN TYROSINE KINASE;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; BRAIN TUMOR; CAPILLARY ENDOTHELIUM; CELL PROLIFERATION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG RELEASE; EXPRESSION VECTOR; GENETIC ENGINEERING; GENETIC TRANSFECTION; GLIOMA; HUMAN; HUMAN CELL; LONG TERM CARE; MICROENCAPSULATION; NONHUMAN; NUDE MOUSE; PHENOTYPE; PRIORITY JOURNAL; TUMOR CELL LINE;

ALGINATES; ANGIOGENESIS INHIBITORS; ANIMALS; BIOCOMPATIBLE MATERIALS; BRAIN NEOPLASMS; CAPILLARIES; CAPSULES; CATTLE; CELL TRANSPLANTATION; CELLS, CULTURED; COLLAGEN; CRICETINAE; ENDOSTATINS; ENDOTHELIUM, VASCULAR; GENETIC VECTORS; GLIOMA; HUMANS; MICE; MICE, NUDE; PEPTIDE FRAGMENTS; POLYLYSINE; RECOMBINANT PROTEINS; SWINE; TRANSFECTION; TRANSPLANTATION, HETEROLOGOUS;

ANIMALIA; BOVINAE; CRICETINAE; MUS MUSCULUS; SUIDAE;

EID: 0035172407     PISSN: 10870156     EISSN: None     Source Type: Journal    
DOI: 10.1038/83481     Document Type: Article

References (38)

1. Brain tumor. Part 2
2. Microvessel density is a prognostic indicator for patients with astroglial brain tumors
3. Angiogenesis inhibitors generated by tumors
4. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
5. A cancer therapy resistant to resistance
6. A flanking attack on cancer
7. Prolonged tumor dormancy by prevention of neovascularization in the vitreous
8. Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression
9. Viral vector-mediated transduction of a modified platelet factor 4 cDNA inhibits angiogenesis and tumor growth
10. AGM-1470 inhibits the growth of human glioblastoma cells in vitro and in vivo
11. Inhibition of angiogenesis and growth of human nerve-sheath tumors by AGM-1470
12. Inhibition of growth and angiogenesis of human neurofibrosarcoma by heparin and hydrocortisone
13. Growth inhibition of the 9L glioma using polymers to release heparin and cortisone acetate
14. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma
15. Angiostatin suppresses malignant glioma growth in vivo
16. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth
17. Microencapsulated islets as bioartificial endocrine pancreas
18. Insulin independence in a type 1 diabetic patient after encapsulated islets transplantation
19. Encapsulated cell technology
20. Growth hormone gene therapy using Encapsulated myoblast
21. Controlled release of therapeutic agents: Slow delivery and cell encapsulation
22. Modulation of systemic cytokine levels by implantation of alginate-encapsulated cells
23. Characterization of microencapsulated liposome systems for the controlled delivery of liposome-associated macromolecules
24. Microencapsulated genetically engineered live E. coli DH5 cells administered orally to maintain normal plasma urea level in uremic rats
25. Supratentorial malignant glioma: Patterns of recurrence and implications for external beam local treatment
26. Malignant astrocytomas: Focal tumor recurrence after focal external beam radiation therapy
27. Patterns of recurrence of glioblastoma multiforme after external irradiation followed by implant boost
28. Angiostatin induces and sustains dormancy of human primary tumors in mice
29. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance
30. Methods for quantifying the transport of drugs across brain barrier systems
31. Haemodynamic and transport barriers to the treatment of solid tumours
32. Endostatin inhibits VEGF-induced endothelial cell migration and tumor growth independently of zinc binding
33. Systemic inhibition of tumor growth and tumor metastases by intramuscular administration of the endostatin gene
34. Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli
35. Angiogenesis by fibroblast growth factor 4 is mediated through an autocrine upregulation of vascular endothelial growth factor expression
36. Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor
37. KDR activation in astrocytic neoplasms
38. Tumor angiogenesis and metastasis - Correlation in invasive breast carcinoma